Discovery of a Potent, Nonpolyglutamatable Inhibitor of Glycinamide Ribonucleotide Transformylase-Reference-Cited by-同舟云学术

Discovery of a Potent, Nonpolyglutamatable Inhibitor of Glycinamide Ribonucleotide Transformylase

Published:2006-04-18 Issue:10 Volume:49 Page:2998-3002
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

DeMartino Jessica K.¹,Hwang Inkyu¹,Xu Lan¹,Wilson Ian A.¹,Boger Dale L.¹

Affiliation:

1. Departments of Chemistry, Molecular Biology, and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0601147

Reference26 articles.

1. BIOSYNTHESIS OF THE PURINES

2. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic strategies for anticancer antifolates;New Strategies Targeting Cancer Metabolism;2022

2. The Intersection of Purine and Mitochondrial Metabolism in Cancer;Cells;2021-09-30

3. pH Effects and Cooperativity among Key Titratable Residues for Escherichia coli Glycinamide Ribonucleotide Transformylase;The Journal of Physical Chemistry B;2021-08-05

4. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight;ACS Pharmacology & Translational Science;2021-03-01

5. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities;Cancer Letters;2020-02